EIF4E and cancer: For example, in cancer models, Salubrinal combined with 4E1RCat (a dual inhibitor of eIF4E:4E-BP1 and eIF4E:eIF4G) decreased protein synthesis in melanoma cells and impeded tumor growth in mice [121].